The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed to at least that many doses and could increase shipments later if organizations involved show they are able to distribute the pills well, noting most will be available toward the end of the year.
"We are working with the ACT-A partnership on supply of Paxlovid for low- and lower middle-income countries as part of our commitment to equitable access for the COVID-19 oral treatment," Pfizer spokesperson Kit Longley said in a statement without providing details. Paxlovid is expected to be a key tool in treating COVID-19 after it reduced hospitalizations in high-risk patients by around 90% in a clinical trial. The results were significantly better than those from a clinical trial of Merck Inc's MRK.N rival oral antiviral molnupiravir.
The 10 million treatment courses destined for lower-income countries is "nowhere near enough," Peter Maybarduk, director of Public Citizen's Access to Medicines program, said in an email.
CTV doing damage control!! lol. It’s fooling nobody!!
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.